Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2012
DOI: 10.1021/mp300098t
|View full text |Cite
|
Sign up to set email alerts
|

Heparan Sulfate Proteoglycan-Mediated Entry Pathway for Charged Tri-Platinum Compounds: Differential Cellular Accumulation Mechanisms for Platinum

Abstract: We examined the mechanism of accumulation of charged polynuclear platinum complexes (PPCs), based on analogy of polyarginine interactions with the cell surface heparan sulfate proteoglycan (HSPG) family of protein-linked glycosoaminoglycan polysaccharides (GAGs). GAGS such as heparan sulfate (HS) and chondroitin sulfate (CS) mediate the cellular entry of many charged molecules. Fluorescence microscopy and flow cytometry showed that PPCs, but not the neutral cisplatin or oxaliplatin, blocked the cellular entry … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

6
69
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
7

Relationship

6
1

Authors

Journals

citations
Cited by 36 publications
(76 citation statements)
references
References 45 publications
6
69
0
1
Order By: Relevance
“…10 Given the measured affinity of TAMRA-R 9 to heparin is K d = 109 nM 9 , similar to typical receptor-ligand interactions, PPCs must have similar high affinity. 10 The interactions between the amine groups of the triplatinum compounds and the phosphate groups of the DNA backbone are very similar to those of the guanidine groups on arginine (Figure 1). Conceptualizing polynuclear platinum complexes as “polyarginine mimics’ has been very useful in drawing analogies between the DNA recognition modes of the arginine fork and the phosphate clamp, a third mode of ligand-DNA binding discrete from the classical intercalator and minor groove binders.…”
mentioning
confidence: 99%
See 2 more Smart Citations
“…10 Given the measured affinity of TAMRA-R 9 to heparin is K d = 109 nM 9 , similar to typical receptor-ligand interactions, PPCs must have similar high affinity. 10 The interactions between the amine groups of the triplatinum compounds and the phosphate groups of the DNA backbone are very similar to those of the guanidine groups on arginine (Figure 1). Conceptualizing polynuclear platinum complexes as “polyarginine mimics’ has been very useful in drawing analogies between the DNA recognition modes of the arginine fork and the phosphate clamp, a third mode of ligand-DNA binding discrete from the classical intercalator and minor groove binders.…”
mentioning
confidence: 99%
“…These results are consistent with the greater efficacy of TriplatinNC compared to AH44 to compete with TAMRA-R 9 for HSPG binding. 10 …”
mentioning
confidence: 99%
See 1 more Smart Citation
“…A 1:1 adduct of 12 :N-AcWLASW-OH is observed by ESI Mass Spectrometry. Compound 12 in standard MTT assays, [3], showed an IC 50 of approximately 1.5 μM in the highly cisplatin-sensitive A2780 ovarian cancer cell line while the corresponding value in OsACL, an osteosarcoma containing wtp53 and which overexpresses mdm2 protein, [24], is approximately 20 μM. The interpretation of these results with respect to the proposed target may be explored more fully with protein inhibition and expression assays [25].…”
Section: Discussionmentioning
confidence: 99%
“…Specifically from our own laboratory, non-covalent H-bonding interactions on polynuclear platinum compounds (PPCs) have described the phosphate clamp, a third mode of (ligand)-DNA interaction discrete from the classical minor groove binding and intercalation [1,2]. An unedited mode of cellular accumulation of PPCs identifying HeparanSulfateProteoGlycans (HSPGs) as receptors through initial non-covalent binding to oligosaccharides has significant implications for new target discovery for coordination compounds [3,4]. Stacking π-π interactions play a fundamental role in biology and especially DNA/RNA-protein selective recognition.…”
Section: Introductionmentioning
confidence: 99%